Global Gene Corp announced a collaboration with The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), Department of Radiation Oncology, to develop a better understanding of rare cancers in South Asian and Indian populations.
The collaboration will be to molecularly profile tumors using cutting edge technology utilized in the laboratory of Arnab Chakravarti, M.D., at the OSUCCC - James. Global Gene Corp will provide access to longitudinal, genomics data, insights and analytics for unexplored patient populations in South Asians.
"To help fight cancer, one has to build a representative and unique perspective that leads to novel insights. India and South East Asia have different manifestations of cancer compared to cancers that are considered rare in the West. We aim to study why" Chakravarti, chairman of the department of radiation oncology at the OSUCCC – James said.